Concepedia

Zachary A. Hing

ZA

8

Publications

575

Citations

8

H-Index

2012

Active since

Affiliations

The Ohio State University(Current)

Center for Biologics Evaluation and Research

The University of Texas Southwestern Medical Center

Karyopharm Therapeutics (United States)

Zachary A. Hing is an author at The Ohio State University specializing in medicine, developmental biology, and proteomics.

Top concepts

Publications per year

2012–2023

8

Publications

8

BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

Hatice Gülçin Özer, Dalia El‐Gamal, Ben Powell et al. · Cancer Discovery · 2018 · 135 citations · Full text

Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies

Zachary A. Hing, Ho Yee Joyce Fung, Punithavathi Ranganathan et al. · Leukemia · 2016 · 134 citations · Full text

, , +9

Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia

Zachary A. Hing, Rose Mantel, Kyle A. Beckwith et al. · Blood · 2015 · 91 citations · Full text

Characterization of Coding Synonymous and Non-Synonymous Variants in ADAMTS13 Using Ex Vivo and In Silico Approaches

Nathan C. Edwards, Zachary A. Hing, Avital Perry et al. · PLoS ONE · 2012 · 90 citations · Full text

, , +23

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

Janek S. Walker, Zachary A. Hing, Bonnie K. Harrington et al. · Journal of Hematology & Oncology · 2021 · 51 citations · Full text

Rows per page

1–5 of 8